July 31 (UPI) -- A jury on Monday began to deliberate in the federal securities fraud trial of Martin Shkreli, the former head of Turing Pharmaceuticals who gained notoriety two years ago for hiking the cost of an AIDS medication by 5,000 percent.
Shkreli was arrested in December 2015 on charges of securities fraud and wire fraud. Prosecutors allege he ran a "Ponzi scheme" between 2009 and 2014 in which he bilked investors out of a total of $11 million.